Surfactant Protein B Plasma Levels: Reliability as a Biomarker in COPD Patients.
Michela D'AscanioFausta ViccaroDario PizzirussoGiulio GuerrieriAlessandra PagliucaSimone GuerriniMarta InnammoratoClaudia De VitisSalvatore RaffaAldo PezzutoAlberto RicciPublished in: Biomedicines (2023)
SpB may be considered as a useful marker in COPD assessment and provides prognostic information on lung functional decline. Despite its usefulness, further studies are needed to define its reliability as a biomarker.